Channappanavar Rudragouda, Fett Craig, Mack Matthias, Ten Eyck Patrick P, Meyerholz David K, Perlman Stanley
Department of Microbiology, University of Iowa, Iowa City, IA 52242.
Department of Internal Medicine, University Hospital Regensburg, Regensburg 93042, Germany.
J Immunol. 2017 May 15;198(10):4046-4053. doi: 10.4049/jimmunol.1601896. Epub 2017 Apr 3.
Pathogenic human coronaviruses (CoVs), such as the severe acute respiratory syndrome (SARS)-CoV and the Middle East respiratory syndrome-CoV, cause acute respiratory illness. Epidemiological data from the 2002-2003 SARS epidemic and recent Middle East respiratory syndrome outbreak indicate that there may be sex-dependent differences in disease outcomes. To investigate these differences, we infected male and female mice of different age groups with SARS-CoV and analyzed their susceptibility to the infection. Our results showed that male mice were more susceptible to SARS-CoV infection compared with age-matched females. The degree of sex bias to SARS-CoV infection increased with advancing age, such that middle-aged mice showed much more pronounced differences compared with young mice. Enhanced susceptibility of male mice to SARS-CoV was associated with elevated virus titers, enhanced vascular leakage, and alveolar edema. These changes were accompanied by increased accumulation of inflammatory monocyte macrophages and neutrophils in the lungs of male mice, and depletion of inflammatory monocyte macrophages partially protected these mice from lethal SARS. Moreover, the sex-specific differences were independent of T and B cell responses. Furthermore, ovariectomy or treating female mice with an estrogen receptor antagonist increased mortality, indicating a protective effect for estrogen receptor signaling in mice infected with SARS-CoV. Together, these data suggest that sex differences in the susceptibility to SARS-CoV in mice parallel those observed in patients and also identify estrogen receptor signaling as critical for protection in females.
致病性人类冠状病毒(CoV),如严重急性呼吸综合征(SARS)-CoV和中东呼吸综合征冠状病毒,可引发急性呼吸道疾病。2002-2003年SARS疫情及近期中东呼吸综合征疫情的流行病学数据表明,疾病结局可能存在性别差异。为了研究这些差异,我们用SARS-CoV感染了不同年龄组的雄性和雌性小鼠,并分析了它们对感染的易感性。我们的结果显示,与年龄匹配的雌性小鼠相比,雄性小鼠对SARS-CoV感染更易感。随着年龄增长,雄性小鼠对SARS-CoV感染的性别偏差程度增加,因此中年小鼠与幼年小鼠相比表现出更明显的差异。雄性小鼠对SARS-CoV易感性增强与病毒滴度升高、血管渗漏增加和肺泡水肿有关。这些变化伴随着雄性小鼠肺中炎性单核细胞巨噬细胞和中性粒细胞的积累增加,并且炎性单核细胞巨噬细胞的耗竭部分保护这些小鼠免受致死性SARS的侵害。此外,性别特异性差异与T细胞和B细胞反应无关。此外,卵巢切除术或用雌激素受体拮抗剂处理雌性小鼠会增加死亡率,表明雌激素受体信号传导在感染SARS-CoV的小鼠中具有保护作用。总之,这些数据表明小鼠对SARS-CoV易感性的性别差异与在患者中观察到的相似,并且还确定雌激素受体信号传导对雌性的保护至关重要。